Vaccine developed by methods of molecular biology, genetic engineering and recombinant DNA
Vaccine developed by methods of molecular biology, genetic engineering and recombinant DNA. Highly effective vaccine are based on hybrid proteins (do not contain the viruses themselves). Proposed vaccine are characterized by greater efficiency and safety compared to the commercial vaccines, as well as a wider range of applications. Have no analogues in the world.
The invention is included in the «Prospective inventions» base, Patent № RU 2510281
The invention received a prize at the international exhibition of inventions and innovative technologies «Archimedes»